Increase of secondary mutations may be a drug-resistance mechanism for lung adenocarcinoma after radiation therapy combined with tyrosine kinase inhibitor

類似資料

• Tyrosine Kinase Inhibitor Resistance Increased the Risk of Cerebral Radiation Necrosis After Stereotactic Radiosurgery in Brain Metastases of Non-small-Cell Lung Cancer: A Multi-Institutional Retrospective Case-Control Study
  著者:: Zhuang, Hongqing, 等
  出版事項: (2020)
• Uncommon EGFR mutations in lung adenocarcinoma: features and response to tyrosine kinase inhibitors
  著者:: Brindel, Aurélien, 等
  出版事項: (2020)
• EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas
  著者:: Chen, Zhi-Yong, 等
  出版事項: (2012)
• Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma
  著者:: Kim, Eun Young, 等
  出版事項: (2018)
• Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors
  著者:: Sandblom, Viktor, 等
  出版事項: (2020)